Isn’t it funny (not funny ha ha) that our government is the only one who is never to blame for price increases or shortages of any kind. It’s always Big Oil, the military industrial complex, etc. Or in this case, evil Big Pharma. We can’t name one industry that doesn’t get blamed for these occurrences (except of course, Big Education), yet the government, with its penchant for artificially picking winners and losers, escapes all scrutiny. We’re about to see it happen again. And when it has the opposite effect, we’ll all be instructed to once again blame “Big Pharma.”
from Human Events:
“Cold” Medicine: Canadian Drug Imports Will Cost Americans
The solution to drug prices is ending freeriding, not buying Canadian
In the hopes of lowering the cost of prescription drugs for Americans, the Trump Administration announced plans in late July to draft a proposal for the importation and sale of prescription drugs from Canada. The announcement was overshadowed by House Speaker Nancy Pelosi’s drug pricing bill and the bipartisan package before the Senate in September—but is a cause for concern, nonetheless. A dozen states, Congress—even the Trump Administration, despite initial opposition—are now considering such legislation.
If “buy-Canadian” doesn’t sound like a policy consistent with Trump’s platform of putting Americans first, that’s because it isn’t. Importing drugs from Canada is an ineffectual and counterproductive policy. President Trump had it right the first time. The prohibitive drug prices that Americans deal with are not solely caused by pharmaceutical companies; they are primarily the product of a failure of government policy.
Instead of artificial fixes, the Trump Administration should directly address the global freeloading and regulatory glut that’s costing Americans—both in dollars and lives.